-
聚戊糖多硫醇
- names:
Pentosan Polysulfate
- CAS號(hào):
37300-21-3
MDL Number: No data available - MF(分子式): C 10 H 18 O 21 S 4 MW(分子量): 4000-6000
- EINECS:No data available Reaxys Number:No data available
- Pubchem ID:37720 Brand:BIOFOUNT
| 貨品編碼 | 規(guī)格 | 純度 | 價(jià)格 (¥) | 現(xiàn)價(jià)(¥) | 特價(jià)(¥) | 庫存描述 | 數(shù)量 | 總計(jì) (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000639-200mg | 200mg | >98.0% | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | ||
| YZM000639-100mg | 100mg | >98.0% | ¥ 858.00 | ¥ 858.00 | 2-3天 | ¥ 0.00 |
- 大包裝詢價(jià) 提供各種包裝,敬請(qǐng)垂詢
- 收藏商品 商品點(diǎn)評(píng) 加入購物車 立即購買
| 中文別名 | 聚戊糖多硫醇(37300-21-3),戊聚糖多硫酸鈉,戊聚糖多硫酸鹽,[(2R,3R,4S,5R)-2-羥基-5-[(2S,3R,4S,5R)-5-羥基-3,4-二磺基氧基四氫吡喃-2-基]氧基-3-磺基氧基四氫吡喃-4-基]氫硫酸鹽; |
| 英文別名 | Pentosan Polysulfate(37300-21-3);4-O-(2,3-Di-O-sulfo-β-D-xylopyranosyl)-2,3-di-O-sulfo-β-D-xylopyr anose; |
| CAS號(hào) | 37300-21-3 |
| Inchi | InChI=1S/C10H18O21S4/c11-3-1-26-10(8(31-35(22,23)24)5(3)28-32(13,14)15)27-4-2-25-9(12)7(30-34(19,20)21)6(4)29-33(16,17)18/h3-12H,1-2H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)/t3-,4-,5+,6+,7-,8-,9-,10+/m1/s1 |
| InchiKey | FCCNSUIJIOOXEZ-SJYYZXOBSA-N |
| 分子式 Formula | C 10 H 18 O 21 S 4 |
| 分子量 Molecular Weight | 4000-6000 |
| 溶解度Solubility | 生物體外In Vitro:DMSO溶解度< 1 mg/mL(insoluble or slightly soluble)H2O< 0.1 mg/mL(insoluble) |
| 性狀 | 固體粉末,Power |
| 儲(chǔ)藏條件 Storage conditions | -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
聚戊糖多硫醇(37300-21-3,Pentosan Polysulfate)實(shí)驗(yàn)注意事項(xiàng):
1.實(shí)驗(yàn)前需戴好防護(hù)眼鏡,穿戴防護(hù)服和口罩,佩戴手套,避免與皮膚接觸。
2.實(shí)驗(yàn)過程中如遇到有毒或者刺激性物質(zhì)及有害物質(zhì)產(chǎn)生,必要時(shí)實(shí)驗(yàn)操作需要手套箱內(nèi)完成以免對(duì)實(shí)驗(yàn)人員造成傷害
3.實(shí)驗(yàn)后產(chǎn)生的廢棄物需分類存儲(chǔ),并交于專業(yè)生物廢氣物處理公司處理,以免造成環(huán)境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
Tags:聚戊糖多硫醇試劑,聚戊糖多硫醇雜質(zhì),聚戊糖多硫醇中間體,聚戊糖多硫醇密度,聚戊糖多硫醇合成,聚戊糖多硫醇溶解度,聚戊糖多硫醇旋光度,聚戊糖多硫醇閃點(diǎn),聚戊糖多硫醇結(jié)構(gòu)式,聚戊糖多硫醇購買,
| 產(chǎn)品說明 | 聚戊糖多硫醇(37300-21-3,Pentosan Polysulfate)是一種有效的口服生物可利用的半合成藥物,具有抗炎和促軟骨生成的特性 |
| Introduction | 聚戊糖多硫醇(37300-21-3,Pentosan Polysulfate)is an orally bioavailable medication with antinflammatory and prohondrogenic properties. Pentosan Polysulfate also is a potent and selective antiIVagent. |
| Application1 | Pentosan Polysulfate is used for the treatment of ?interstitial cystitis. |
| Application2 | 聚戊糖多硫醇是細(xì)胞膜通透性抑制劑。 |
| Application3 |
聚戊糖多硫醇(37300-21-3,Pentosan Polysulfate)藥理學(xué):
聚戊糖多硫醇是一種低分子量的肝素樣化合物。它具有抗凝血和纖溶作用。 聚戊糖多硫醇是半合成的肝素樣葡糖胺聚糖。盡管其作用機(jī)理尚不清楚,但戊聚戊糖多硫醇可通過防止刺激性溶質(zhì)到達(dá)被其包裹的細(xì)胞來控制細(xì)胞的通透性。經(jīng)口服施用,排泄的聚戊糖多硫醇粘附在膀胱壁上,防止刺激物進(jìn)入膀胱細(xì)胞以及間質(zhì)性膀胱炎(IC)的發(fā)展或進(jìn)展,這是一些化學(xué)療法的并發(fā)癥。該試劑還具有抗凝血和纖溶特性。聚戊糖多硫醇是抗凝劑,防止血液凝結(jié)的代理。 聚戊糖多硫醇是木糖硫酸氫鹽的聚合物,每個(gè)碳水化合物單體包含兩個(gè)硫酸鹽基團(tuán)。它結(jié)合成纖維細(xì)胞生長因子(FGFs)以及其他肝素結(jié)合生長因子。已經(jīng)顯示它也與FGFR-1 的肝素結(jié)合位點(diǎn)相互作用。聚戊糖多硫醇抑制轉(zhuǎn)染了FGF-4的SW13腎上腺皮質(zhì)細(xì)胞的生長以及轉(zhuǎn)染了FGF-1或FGF-4的MCF-7乳腺癌細(xì)胞的致瘤性。
| 警示圖 | |
| 危險(xiǎn)性 | warning |
| 危險(xiǎn)性警示 | Not available |
| 安全聲明 | H303吞入可能有害+H313皮膚接觸可能有害+H2413吸入可能對(duì)身體有害 |
| 安全防護(hù) | P264處理后徹底清洗+P280戴防護(hù)手套/穿防護(hù)服/戴防護(hù)眼罩/戴防護(hù)面具+P305如果進(jìn)入眼睛+P351用水小心沖洗幾分鐘+P338取出隱形眼鏡(如果有)并且易于操作,繼續(xù)沖洗+P337如果眼睛刺激持續(xù)+P2393獲得醫(yī)療建議/護(hù)理 |
| 備注 | 實(shí)驗(yàn)過程中防止吸入、食入,做好安全防護(hù) |
| Schuchman EH, et al. Pentosan polysulfate: a novel therapy for the mucopolysaccharidoses. PLoS One. 2013;8(1):e54459. |
| Baba M, et al. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Res. 1988 Sep;9(6):335-43. |
| Wu J, et al. Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice. Lab Invest. 2011 Oct;91(10):1459-71. |
聚戊糖多硫醇(37300-21-3,Pentosan Polysulfate)參考文獻(xiàn):
1,戊聚糖鈉和硫酸鈣多硫酸鹽的抗凝和抗血栓形成作用的實(shí)驗(yàn)研究。
Giedroj? J;Radziwon P;Klimiuk M;Bielawiec M;Breddin HK;K?oczko J J Physiol Pharmacol. 1999 Mar;50(1):111-9.
In the present study we have compared the antithrombotic and anticoagulant properties of sodium and calcium derivatives of pentosan polysulphate (Na-PPS, Ca-PPS). The antithrombotic effect of these agents have been investigated in an experimental thrombosis model in which rat mesenteric venules diameter of 20-30 microm were injured by well defined Argon laser lesions. Furthermore, the in vivo and in vitro anticoagulant activities (aPTT, Heptest) of these agents have been studied. Thrombus formation was significantly inhibited after s.c. injection of Na-PPS and Ca-PPS in doses above 10 mg/kg. The duration of the antithrombotic effect lasted 8 h for Na-PPS and 12 h for Ca-PPS. After oral administration of Na-PPS an antithrombotic effect was not observed. Oral application of Ca-PPS in doses higher than 20 mg/kg significantly inhibited thrombus formation. Na-PPS and Ca-PPS markedly prolonged clotting time in aPTT and Heptest in concentrations ranging from 0.01 to 0.2 mg/ml rat PTT. Two h after s.c. administration of these agents in a dose 10 mg/kg, the aPTT increased 3-fold and Heptest 2.5-fold compared to controls. After oral application of 50 mg/kg Na-PPS and Ca-PPS no effect on coagulation test could be measured.
2.硫酸化多糖的細(xì)胞表面受體:巨噬細(xì)胞亞群的潛在標(biāo)志物。
Chong AS;Parish CR Immunology. 1986 Jun;58(2):277-84.
The expression of a diverse array of receptors for sulphated polysaccharides on lymphocytes has been demonstrated by Parish & Snowden (1985). This paper presents evidence to suggest that other cell types, namely macrophages, polymorphonuclear leucocytes, mast cells and fibroblasts, can bind similar polysaccharides. Using a rosetting assay and eleven structurally unique polysaccharides, each cell type was observed to bind a characteristic array of these polysaccharides. Analysis of the polysaccharide reactivity of macrophages revealed that BCG-activated and thioglycollate-elicited macrophages express an expanded repertoire of reactivity compared to resident peritoneal macrophages. For example, only thioglycollate-elicited macrophages, but not resident and BCG-activated peritoneal macrophages, reacted with the glycosaminoglycans, chondroitin-4-sulphate, chondroitin-6-sulphate and dermatan sulphate, while both BCG- and thioglycolate-activated, but not resident peritoneal macrophages, bound pentosan polysulphate-coupled sheep erythrocytes. The expression of the receptors for chondroitin-4 and -6-sulphate was observed to be cyclic and peaked at 2 and 5-6 days after thioglycollate treatment.
3.評(píng)論文章:放射直腸疾病的當(dāng)前治療選擇
Hong JJ;Park W;Ehrenpreis ED Aliment Pharmacol Ther. 2001 Sep;15(9):1253-62.
Radiation proctopathy is a common unfortunate complication following radiation therapy of pelvic malignancies. Symptoms of chronic radiation proctopathy include haematochezia, urgency, constipation, tenesmus, diarrhoea and rectal pain. Currently, a wide variety of pharmacological options, endoscopic cautery techniques and surgical procedures have been proposed for the treatment of chronic radiation proctopathy. Although these have been proposed primarily as treatment for rectal bleeding, the control of other symptoms has been noted with some of these agents. Pharmacological options include 5-aminosalicylic acid preparations, coticosteroid enemas, sucralfate (oral, enemas), formalin, short chain fatty acid enemas, oestrogen/progesterone, hyperbaric oxygen, antioxidants, sodium pentosan polysulphate and misoprostol rectal suppositories. Of these, sucralfate and formalin therapy appear to be effective for bleeding control. Misoprostol rectal suppositories and oral sucralfate may be useful in the prevention of acute and chronic symptoms of radiation proctopathy. Endoscopic cautery techniques have included the use of Nd:YAG laser and argon laser for coagulation of bleeding neovascular telangiectasias.
- 相關(guān)產(chǎn)品
-
< >
- 推薦產(chǎn)品
-
< >
- 最新產(chǎn)品
-
< >
新聞
胞爬片免疫組化染色.png)
怎么做細(xì)胞爬片免疫組化染色實(shí)驗(yàn)
細(xì)胞爬片免疫組化染色,是通過細(xì)胞爬片是讓玻片浸在細(xì)胞培養(yǎng)基內(nèi),細(xì)胞在玻片上生長,主要用于組織學(xué),免疫組織化學(xué)...
2020/7/20 22:04:33

提取病毒RNA的實(shí)驗(yàn)方法
提取病毒RNA方法分別有:異硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26

9月開學(xué)季——助研新學(xué)期 范德送好禮
2025/8/28 15:30:55

Waxfilm 實(shí)驗(yàn)室封口膜:技術(shù)與國際市場(chǎng)的雙重突破
在實(shí)驗(yàn)室耗材領(lǐng)域,封口膜是保障實(shí)驗(yàn)準(zhǔn)確性與穩(wěn)定性的關(guān)鍵產(chǎn)品之一。近年來,Waxfilm?實(shí)驗(yàn)室封口膜憑借其卓...
2025/5/13 13:03:40

Waxfilm實(shí)驗(yàn)室封口膜的5大突破
Waxfilm實(shí)驗(yàn)室封口膜作為生物功能膜領(lǐng)域的國產(chǎn)技術(shù)突破和品牌突破,是生物領(lǐng)域中國技術(shù)發(fā)展的縮影。
2025/5/6 17:02:07

各種微流控芯片鍵合方法的優(yōu)缺點(diǎn)
微流控芯片鍵合:目前主要有激光焊接、熱壓鍵合、膠鍵合、超音波焊接,每種方法都有各自的優(yōu)缺點(diǎn)。本文主要介紹聚酯...
2023/7/28 10:43:09

新一代微流控鍵合解決方案
微流控鍵合解決方案:微流控芯片制造的一個(gè)重要環(huán)節(jié),也是最容易被忽視的--芯片鍵合。其中一個(gè)重要因素是:微流控...
2023/7/27 12:44:28
驗(yàn)動(dòng)物圖.png)
熒光素鉀鹽使用說明
D-熒光素鉀鹽(K+)設(shè)計(jì)用于體外和體內(nèi)生物發(fā)光測(cè)定。D-熒光素的質(zhì)量和純度對(duì)于獲得良好和可重復(fù)的結(jié)果至關(guān)重...
2023/7/20 11:05:11

如何選BSA(牛血清白蛋白)
如何選BSA(牛血清白蛋白):牛血清白蛋白(BSA)有多種形式,如何選擇適合自己的牛血清白蛋白(BSA)是一...
2023/2/14 13:09:18

牛血清白蛋白(BSA)常見問題
牛血清白蛋白(BSA)常見問題:牛血清白蛋白(BSA)在實(shí)驗(yàn)室中是通用的,可用于蛋白質(zhì)印跡、細(xì)胞組織培養(yǎng)、P...
2022/10/19 9:39:51



購物車 


